tiprankstipranks
TipRanksTop Financial ExpertsInsidersSteven Paul

Steven Paul Insider Profile

11 Followers
Steven Paul, Director at Rapport Therapeutics, Inc., holds 863.03K shares in Seaport Therapeutics, Inc. (Ticker: SPTX), holds 41.67K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX).
See the Hottest Stocks Based on Insider Trading >
tipranks
Steven Paul

Steven Paul
Rapport Therapeutics, Inc. (RAPP)
Director

Ranked #1,539 out of 108,328 Corporate Insiders

Profitable Transactions

83%
5 out of 6 Profitable Transactions

Average Return

+119.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$109M
82.06%
16.18%
1.56%
0.19%
0.00% Others
A breakdown of Steven Paul's holdings
See the Top Stocks by Insiders

Insider Roles

Eli Lilly & Co
(LLY)
EVP, Science and Technology
Seaport Therapeutics, Inc.
(SPTX)
Director
Rapport Therapeutics, Inc.
(RAPP)
Director
Alnylam Pharma
(ALNY)
Director
+1 other positions
Roles that Steven Paul holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Karuna Therapeutics
(KRTX)
Rating:Informative Buy
Date:Jul 01, 2019 - Jul 01, 2020
Return:+406.90%
The most profitable trade made by Steven Paul
See the Latest Stocks Traded by Insiders

Steven Paul's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RAPP
Rapport Therapeutics, Inc.
Sep 15, 2025
Director
Informative Buy
1.03M
$1.71M
SPTX
Seaport Therapeutics, Inc.
May 04, 2026
Director
Uninformative Buy
―
$17.66M
SAGE
SAGE Therapeutics
Nov 30, 2022
―
Uninformative Buy
190.80
$5.15M
VYGR
Voyager Therapeutics
―
Director
―
―
KRTX
Karuna Therapeutics
Mar 18, 2024
―
Uninformative Sell
49.82M
$0.00
ALNY
Alnylam Pharma
Apr 05, 2022
Director
Uninformative Sell
2.56M
$205.52K
SIAL
Sigma-Aldrich Corp
Nov 19, 2015
―
Uninformative Sell
66.92K
―
LLY
Eli Lilly & Co
Feb 03, 2010
EVP, Science and Technology
Uninformative Buy
610.79K
$89.54M
List of latest transactions for each holding click on a transaction to see Steven Paul's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Steven Paul insider profile FAQ

What is the percentage of profitable transactions made by Steven Paul?
The percentage of profitable transactions made by Steven Paul is 83%.
    What is the average return per transaction made by Steven Paul?
    The average return per transaction made by Steven Paul is 119.80%.
      What stocks does Steven Paul hold?
      Steven Paul holds: RAPP, SPTX, SAGE, VYGR, KRTX, ALNY, SIAL, LLY stocks.
        What was Steven Paul’s latest transaction?
        Steven Paul latest transaction was an Uninformative Buy of ―.
          What was Steven Paul's most profitable transaction?
          Steven Paul’s most profitable transaction was an Informative Buy of KRTX stock on July 1, 2019. The return on the trade was 406.90%.
            What is Steven Paul's role in Rapport Therapeutics, Inc.?
            Steven Paul's role in Rapport Therapeutics, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.